Neha Krishnamohan
Director/Board Member at ARCUTIS BIOTHERAPEUTICS, INC.
Net worth: 55 565 $ as of 30/03/2024
Profile
Neha Krishnamohan is an Independent Director at Arcutis Biotherapeutics, Inc. She previously worked as a Vice President-Healthcare Investment Banking at The Goldman Sachs Group, Inc. from 2015 to 2021.
She also served as the CFO & Executive VP-Corporate Development at Kinnate Biopharma, Inc. from 2021 to 2024.
Ms. Krishnamohan completed her undergraduate degree at Duke University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/05/2023 | 5,607 ( 0.00% ) | 55 565 $ | 30/03/2024 | |
KINNATE BIOPHARMA, INC.
-.--% | 02/04/2024 | 0 ( -.--% ) | - $ | 30/03/2024 |
Neha Krishnamohan active positions
| Companies | Position | Start |
|---|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Director/Board Member | 01/09/2022 |
Former positions of Neha Krishnamohan
| Companies | Position | End |
|---|---|---|
| KINNATE BIOPHARMA INC. | Director of Finance/CFO | 02/04/2024 |
| THE GOLDMAN SACHS GROUP, INC. | Corporate Officer/Principal | 30/04/2021 |
Training of Neha Krishnamohan
| Duke University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| THE GOLDMAN SACHS GROUP, INC. | Finance |
| ARCUTIS BIOTHERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Kinnate Biopharma, Inc.
 Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Kinnate Biopharma, Inc. operates as a biopharmaceutical company engaged in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. Kaldor and Eric A. Murphy in January 2018 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Neha Krishnamohan
